Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

Condition:   Liver Cancer Interventions:   Drug: Bevacizumab;   Drug: Atezolizumab;   Drug: Sofosbuvir;   Drug: Velpatasvir;   Drug: Voxilaprevir;   Drug: Ribavirin Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials